|
首字母导航: |
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
Name |
INN |
Revision |
Published |
Additional Information |
| Olansek | INN: olanzapine | Marketing Authorisation withdrawn (06/06/03) | ||
| Olanzapine Mylan | INN: olanzapine | 16/10/08 | ||
| Olanzapine Neopharma | INN: olanzapine | Rev. 3 | 16/12/08 | |
| Olanzapine Teva | INN: olanzapine | Rev. 4 | 16/12/08 | |
| Omnitrope | INN: somatropin | Rev. 4 | 23/04/08 | |
| Onsenal | INN: celecoxib | Rev. 10 | 01/04/09 | |
| Opatanol | INN: olopatadine | Rev. 8 | 13/02/09 | |
| Oprymea | INN: pramipexole | Rev. 2 | 27/05/09 | |
| Optaflu | Common name: Influenza vaccine (surface antigen, inactivated, prepared in cell culture) | Rev. 3 | 11/05/09 | |
| Opgenra | INN: eptotermin alfa | Rev. 1 | 20/05/09 | |
| OptiMARK | INN: gadoversetamide | Rev. 2 | 23/04/09 | |
| Optison | INN: perflutren | Rev. 13 | 16/07/08 | Marketing authorisation suspended (16/07/08) |
| Optisulin | INN: insulin glargine | Rev. 9 | 13/05/09 | |
| Optruma | INN: raloxifene | Rev. 17 | 03/09/08 | |
| Opulis | INN: desloratadine | Marketing authorisation withdrawn (18/05/04) | ||
| Orencia | INN: abatacept | Rev. 3 | 14/04/09 | |
| Orfadin | INN: nitisinone | Rev. 3 | 27/11/07 | |
| Orgalutran | INN: ganirelix | Rev. 8 | 29/02/08 | |
| Orlistat GSK | INN: orlistat | 27/07/07 | Renamed?alli | |
| Osigraft | INN: eptotermin alfa | Rev. 6 | 21/04/08 | |
| Osteogenic protein-1 | INN: osteogent protein-1: BMP-7 | See?Osigraft | ||
| Osseor | INN: strontium ranelate | Rev. 5 | 23/03/09 | Press Release (16/11/07) |
| Ovitrelle | INN: choriogonadotropin alfa | Rev. 10 | 24/04/09 | |
| Oxybutynin Nicobrand | INN: oxybutynin | RenamedKentera |
|
||||||||||||||||||||||||||||||||
